newsfilter
← Latest News
Business Wire·

Delcath Systems Reports Second Quarter 2025 Results and Business Highlights

Conference Call Today at 8:30 a.m. Eastern Time Delcath Systems, Inc. (NASDAQ:DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic liver cancers,